Positive late-stage study results position the company to file for clearance of what could be the first narcolepsy drug that targets orexin proteins.
Takeda to seek approval of new kind of narcolepsy drug after study data
Positive late-stage study results position the company to file for clearance of what could be the first narcolepsy drug that targets orexin proteins.